Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Potential BPH therapy from Glaxo Wellcome

Sep. 6, 1996

5alpha-Reductase inhibitors for BPH

Sep. 6, 1996

Expanded H-BIG clinical development program announced

Aug. 30, 1996

OP-1 role in kidney formation investigated

Aug. 30, 1996

Taisho discloses agents for urinary incontinence

Aug. 30, 1996

Reliance approved for marketing in U.S.

Aug. 30, 1996

Potential BPH therapeutics from Poli Industria Chimica

Aug. 30, 1996

U.S. agreement announced for ProstaFlo

Aug. 30, 1996

Terazosin and finasteride go head-to-head in BPH patients

Aug. 30, 1996

McGill University researchers improve safety of cell therapy

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...